Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.

Raivio P, Suojaranta-Ylinen R, Kuitunen AH.

Ann Thorac Surg. 2005 Jul;80(1):66-71.

PMID:
15975342
2.

Potential role of recombinant factor VIIa as a hemostatic agent.

Hedner U, Erhardtsen E.

Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9. Review.

PMID:
16224390
3.

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.

Guzzetta NA, Russell IA, Williams GD.

Anesth Analg. 2012 Aug;115(2):364-78. doi: 10.1213/ANE.0b013e31825aff10. Epub 2012 May 31. Review.

PMID:
22652310
4.
5.

Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.

Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS.

Ann Intern Med. 2011 Apr 19;154(8):529-40. doi: 10.7326/0003-4819-154-8-201104190-00004. Review.

6.

[Recombinant activated factor VII in the postanesthetic recovery unit: review of 16 cases].

Etxániz Alvarez A, Pita Zapata E, Rama Maceiras P, Duro Tacón J, Pose Cambeiro P.

Rev Esp Anestesiol Reanim. 2006 Mar;53(3):159-62. Review. Spanish.

PMID:
16671259
7.

Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data.

von Heymann C, Jonas S, Spies C, Wernecke KD, Ziemer S, Janssen D, Koscielny J.

Crit Care. 2008;12(1):R14. doi: 10.1186/cc6788. Epub 2008 Feb 15. Review.

8.

Recombinant activated factor VII in cardiac surgery: a systematic review.

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Ann Thorac Surg. 2007 Feb;83(2):707-14. Review.

PMID:
17258029
9.

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?

Okonta KE, Edwin F, Falase B.

Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):690-4. Epub 2012 Jul 18. Review.

10.

Recombinant factor VIIa in the treatment of bleeding.

Midathada MV, Mehta P, Waner M, Fink LM.

Am J Clin Pathol. 2004 Jan;121(1):124-37. Review.

PMID:
14750250
11.

Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.

Mayo A, Misgav M, Kluger Y, Geenberg R, Pauzner D, Klausner J, Ben-Tal O.

Vox Sang. 2004 Jul;87(1):34-40. Review.

PMID:
15260820
12.

Safety profile of recombinant factor VIIa.

Roberts HR, Monroe DM 3rd, Hoffman M.

Semin Hematol. 2004 Jan;41(1 Suppl 1):101-8. Review.

PMID:
14872430
13.

Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?

Kogan A, Berman M, Stein M, Vidne BA, Raanani E.

J Cardiovasc Surg (Torino). 2004 Dec;45(6):569-71. Review.

PMID:
15746637
14.
15.

The potential use of recombinant activated factor VII in trauma and surgery.

Sapsford W.

Scand J Surg. 2004;93(1):17-23. Review.

PMID:
15116814
16.

Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safety.

Squizzato A, Ageno W.

Curr Drug Saf. 2007 May;2(2):155-61. Review.

PMID:
18690962
17.

[Recombinant activated factor VII for perioperative bleeding].

López R, Aeschlimann N, Carvajal C, Lema G.

Rev Med Chil. 2009 Jun;137(6):837-43. doi: /S0034-98872009000600016. Epub 2009 Sep 4. Review. Spanish.

18.

Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.

DiDomenico RJ, Massad MG, Kpodonu J, Navarro RA, Geha AS.

Chest. 2005 May;127(5):1828-35. Review.

PMID:
15888865
19.

'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.

Clark AD, Gordon WC, Walker ID, Tait RC.

Vox Sang. 2004 Feb;86(2):120-4. Review.

PMID:
15023181
20.

Supplemental Content

Support Center